| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.08 | 0.6 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.6 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.04 | 0.6 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |